Applications of Biotechnology in Oncology 2013
DOI: 10.1007/978-1-4614-9245-0_5
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers of Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 264 publications
0
1
0
Order By: Relevance
“…Recently, there has been a large number of studies on the Ki-67 marker index and its role in cancer, and it has been found that the expression level of Ki-67 increases successively from benign breast tumors, to ductal carcinoma in situ, and then to invasive breast cancer, and this is believed to be related to the occurrence, development, recurrence, and metastasis of some tumors. In normal breast tissues, the expression level of Ki-67 is extremely low (< 3%), and it is not expressed in ER-negative cells [ 3 ]. So, a poor prognosis in clinical practice is usually associated with a high expression of Ki-67, but patients with a high expression of Ki-67 may have a better response to chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, there has been a large number of studies on the Ki-67 marker index and its role in cancer, and it has been found that the expression level of Ki-67 increases successively from benign breast tumors, to ductal carcinoma in situ, and then to invasive breast cancer, and this is believed to be related to the occurrence, development, recurrence, and metastasis of some tumors. In normal breast tissues, the expression level of Ki-67 is extremely low (< 3%), and it is not expressed in ER-negative cells [ 3 ]. So, a poor prognosis in clinical practice is usually associated with a high expression of Ki-67, but patients with a high expression of Ki-67 may have a better response to chemotherapy.…”
Section: Discussionmentioning
confidence: 99%